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ABSTRACT
The pleiotropic CCCTC-binding factor (CTCF) plays
a role in homologous recombination (HR) repair of
DNA double-strand breaks (DSBs). However, the pre-
cise mechanistic role of CTCF in HR remains largely
unclear. Here, we show that CTCF engages in DNA
end resection, which is the initial, crucial step in HR,
through its interactions with MRE11 and CtIP. Deple-
tion of CTCF profoundly impairs HR and attenuates
CtIP recruitment at DSBs. CTCF physically interacts
with MRE11 and CtIP and promotes CtIP recruitment
to sites of DNA damage. Subsequently, CTCF facili-
tates DNA end resection to allow HR, in conjunction
with MRE11–CtIP. Notably, the zinc finger domain of
CTCF binds to both MRE11 and CtIP and enables
proficient CtIP recruitment, DNA end resection and
HR. The N-terminus of CTCF is able to bind to only
MRE11 and its C-terminus is incapable of binding to
MRE11 and CtIP, thereby resulting in compromised
CtIP recruitment, DSB resection and HR. Overall, this
suggests an important function of CTCF in DNA end
resection through the recruitment of CtIP at DSBs.
Collectively, our findings identify a critical role of
CTCF at the first control point in selecting the HR
repair pathway.
INTRODUCTION
DNA double-strand breaks (DSBs) represent the most
damaging DNA injuries that can compromise genomic in-
tegrity and viability. DSBs can result from exogenous (UV,
ionizing radiation and cytotoxic chemicals) and endoge-
nous (cellularmetabolites, reactive oxygen species and repli-
cation errors) insults. DSBs, if left unrepaired, can lead to
fatal diseases, including cancer, growth and mental retar-
dation, immune deficiency and developmental defects. To
repair DSBs, eukaryotic cells employ mutually exclusive
error-prone non-homologous end joining (NHEJ) or error-
free homologous recombination (HR) repair. NHEJ in-
volves ligation of the brokenDNA ends andmay create mu-
tations, given that a homologous template is not available
for repair. HR repair employs mostly homologous DNA in
the sister chromatid as a template, which restores the cor-
rect DNA sequence. HR repair occurs predominantly dur-
ing the S andG2 phases of the cell cycle, while NHEJ occurs
throughout G1, S and G2.
The first control point for the DSB repair pathway oc-
curs at the processing of the 5′ DNA end resection, which
is catalyzed by MRE11 and CtIP (1,2). DNA end resec-
tion inversely influences the selection of the two major DSB
repair pathways. Accordingly, extensive end resection sup-
presses NHEJ and permits HR repair (3). HR repair com-
mences with the formation of extensive 3′-overhang single-
stranded DNA (ssDNA), which requires the recruitment
of MRE11 and CtIP at the DSB sites, facilitation of the
nuclease activity of MRE11 controlled by CtIP, and in-
volvement of the nucleases EXO1 and BLM/DNA2. Repli-
cation protein A (RPA) loads rapidly onto the resulting
ssDNA and is simultaneously phosphorylated (3). Subse-
quently, the recombinase RAD51 displaces RPA in con-
cert with BRCA1–BARD1, PALB2 and BRCA2 to form a
helical nucleoprotein filament, thereby allowing homology
search, strand invasion and sister chromatid exchange (4,5).
Therefore, DNA end resection is a key step that controls the
choice of the DSB repair pathway.
Although extensive studies have uncovered much about
these critical steps in the regulation of DNA end resec-
tion and HR pathway choice between different DSB repair
mechanisms, the process is complex and involves many ad-
ditional proteins. Hence, how DSB repair proteins play a
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role in selecting the HR repair pathway within this exquisite
network and how this process is controlled are largely un-
derexplored.
Recently, a novel role of the multifunctional nuclear
protein CCCTC-binding factor (CTCF) in HR-mediated
DSB repair has been unveiled (6). CTCF is a transcrip-
tion factor with 11 zinc finger (ZF) domains that function
in many nuclear processes, including genomic organization,
transcriptional regulation, insulator activity, VDJ recombi-
nation and HR-mediated repair. CTCF mutations in hu-
mans are linked to microcephaly and intellectual disabil-
ity (7). In vivo evidence from CTCF knockout mice im-
plicate CTCF as a haploinsufficient tumor suppressor (8),
since heterozygous CTCF+/− mutations display greater sus-
ceptibility to irradiation-induced carcinogenesis, while ho-
mozygous CTCF−/− mutations result in embryonic lethal-
ity (8). Along with these mutation phenotypes, recent find-
ings show that CTCF is recruited to damaged DNA sites
and facilitates HR repair (9–11). Additionally, CTCF in-
teracts with BRCA2 (10) and RAD51 (11), which are im-
plicated in DSB repair by HR. Nevertheless, very little is
known about the precise role of CTCF in HR and the key
mechanism by which CTCF promotes HR.
In this study, we investigated the role of CTCF in HR-
mediated DSB repair and its underlying mechanism. Via
a proteomic approach, we identified MRE11 and CtIP as
novel CTCF-interacting partners with a functional link to
HR repair. We further corroborated that CTCF is recruited
to DNA lesions in an MRE11-dependent manner, followed
by CtIP recruitment, leading to DNA end resection at DSB
sites and initiating HR. Consistent with these observations,
CTCF depletion or truncation mutants are incapable of
binding toCtIP sensitized cells toDNAdamage. These data
provide insights into a previously undescribed role of CTCF
in promoting HR-mediated DNA repair by facilitating the
formation of an initial HR complex for the onset of DNA
end resection.
MATERIALS AND METHODS
Cells and reagents
HeLa, 293T and U2OS cell lines were purchased from
ATCC, and these lines were maintained in Dulbecco’s mod-
ified Eagle’s medium (DMEM; Welgene, Kyung-san, Re-
public of Korea) with 10% FBS (Hyclone, GE Health-
care, Chicago, IL, USA) and 1% penicillin/streptomycin
(Gibco, Thermo Fisher Scientific, Waltham, MA, USA).
U2OS-based DSB reporter cell lines, which stably express
inducible AsiSI-ER (AsiSI-ER-U2OS; a generous gift from
Dr.Gae¨lle Legube,Universite´de Toulouse) (12) or inducible
ER-mCherry-LacI-FokI-DD (FokI-U2OS; a generous gift
from Dr. Roger Greenberg, University of Pennsylvania)
(13) fusion protein, were grown in DMEM-containing
puromycin. U2OS-based DR-GFP, EJ2-GFP, EJ5-GFP
and SA-GFP cells (14) were kindly provided by Dr. Jeremy
Stark (Beckman Research Institute of the City of Hope);
they were maintained in DMEM without sodium pyruvate
(Hyclone) containing 10% FBS and 1 g/ml puromycin
(Sigma-Aldrich, St. Louis, MO, USA). H1299.GC and
H1299.EJ cell lines (15) were kindly provided by Dr. Hans
Will and were cultured in DMEM-containing puromycin
and G418, respectively. All cells were incubated at 37◦C in
a 5% CO2 incubator (BB15, Thermo Fisher Scientific).
Plasmid construction and transfection
GFP- and HA-tagged full-length and truncation mutants
of CTCF and MRE11 were constructed by a classical
PCR method using pEGFP-N1 (Addgene #6085-1) and
pcDNA3-HA, respectively. The oligonucletoide sequences
of the primers used for cloning are shown in Supplementary
Table S1. All junction regions of CTCF and MRE11 con-
structs and the coding sequences of CTCF fragments were
verified by DNA sequencing. Double-stranded short hair-
pin RNAs (shRNAs) targeting CTCF, MRE11 and CtIP
were generated using pSUPER.retro.puro, anH1 promoter-
driven RNA interference retroviral vector (Oligoengine,
Seattle, WA). The sequences of the shRNAs are shown in
Supplementary Table S2. Transfections were performed us-
ing Effectene Transfection Reagent (Qiagen, Carlsbad, CA)
for expression in mammalian cells.
Antibodies
The CTCF antibodies were obtained from Abcam
(ab128873, 1:2000 dilution for immunoblotting (IB) and
1:2000 for immunofluorescence (IF); ab70303, 2 g for
each chromatin immunoprecipitation (ChIP) sample), Cell
Signaling Technology (#2899S, 1:1000 for immunoprecip-
itation (IP)) and Millipore (07-729, 2 g for each ChIP
sample). The other antibodies used for IB, IF, IP and ChIP
analyses were as follows: HA (ab9110 from Abcam, 1:2000
for IB, ChIP, and IP), GFP (ab290 from Abcam, 1:2000
for IB and 1:1000 for IP), H2AX (05-636 from Millipore,
1:2000 for IF and IB; ab2893 from Abcam, 2 g for each
ChIP sample), CtIP (61141 from Active Motif, 1:1000 for
IF, IB, IP and ChIP), RPA (ab2175 fromAbcam, 1:1000 for
IF and 2 g for ChIP), phospho-RPA (S4/S8) (A300-245A
from Bethyl, 1:2000 for IB and IF), MRE11 (ab214 from
Abcam, 1:2000 for IF, ChIP, IP and IB and 2 g for ChIP;
#4895S from Cell Signaling Technology for IP), NBS1
(ab32074 from Abcam, 1:2000 for IB), RAD50 (ab89
from Abcam, 1:2000 for IB and IP), Tubulin (05-829 from
Millipore, 1:3000 for IB), RAD51 (ab176458 from Abcam,
2 g for each ChIP sample), p53 (sc-126 from Santa Cruz,
1:2000 for IB), p21 (05-345 from Millipore, 1:2000 for
IB), phospho-(serine/threonine) ATM/ATR substrate
multi-monoclonal antibody (#6966S from Cell Signaling
Technology, IB), BRCA1 (sc-642 from Santa Cruz, 1:1000
for IB), 53BP1 (NB100-305 from Novus, 1:2000 for IB)
and -actin (sc-47778 from Santa Cruz, 1:3000 for IB).
Tandem affinity purification (TAP) and mass spectrometry
The 293T cells transiently expressing S protein-Flag-
Streptavidin binding peptide (SFB)-tagged CTCF (SFB-
CTCF)were treatedwith or without  -irradiation. The cells
were lysed with TAP-NETN buffer (20 mM Tris-HCl, 100
mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, pH 8.0).
After removal of cell debris by centrifugation, the crude
lysates were incubated with Streptavidin-sepharose beads
(GE Healthcare, Chicago, IL, USA). The bead-bound pro-
teins were washed and eluted with biotin (Sigma Aldrich)
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in TAP-NETN buffer. The eluates were then incubated
with S-protein agarose beads (Millipore, Burlington, MA,
USA). The S-protein bead-bound proteins were washed,
separated by SDS-PAGE and then visualized by staining
with Instant Blue (Expedeon, Heidelberg, Germany). For
LC-MS/MS analyses, the gel lanes were sliced into differ-
ent bands and processed as follows. Briefly, the acetylated
protein bands were divided into 10-mm sections and di-
gested in the gel with trypsin. The tryptic digests were sep-
arated by online reversed-phase chromatography using a
Thermo Scientific EASY-nLC 1200 UHPLC equipped with
an autosampler using a reversed-phase peptide trap Ac-
claim PepMap™ 100 (75-m inner diameter, 2-cm length)
and a reversed-phase analytical column PepMap™ RSLC
C18 (75-m inner diameter, 15-cm length, 3-m particle
size), both from Thermo Scientific. This was followed by
electrospray ionization at a flow rate of 300 nl·min−1. The
chromatography system was coupled in line with an Or-
bitrap Fusion Lumos Mass Spectrometer. The obtained
spectra were screened against the UniProt human database
using Proteome Discoverer Sorcerer 2.1 software with a
SEQUEST-based search algorithm. The comparative anal-
ysis of proteins identified in this study was performed us-
ing Scaffold 4 Q+S. All raw mass spectrometry proteomics
data obtained in this study have been deposited to the Pro-
teomeXchange Consortium via the PRIDE partner reposi-
tory with the dataset identifier PXD014441.
Laser micro-irradiation
U2OS cells were plated onto glass-bottomed culture dishes
(SPL Life Science, Korea) and transfected with the indi-
cated plasmids and siRNA. The cells were presensitized
with 10 M 5-bromo-2′-deoxyuridine (BrdU, Sigma) for
24–30 h and then subjected to laser micro-irradiation using
an Eclipse T1 & A1 confocal system (Nikon Instruments
Inc., Melville, NY, USA) at 405 nm for 3 s (32 lines/s) in
a 37◦C chamber containing 5% CO2. After the laser treat-
ment, the cells were subjected to live-cell imaging or were
processed for IF.
Immunofluorescence
After the indicated treatments (micro-irradiation, etopo-
side, 4′-hydroxytamoxifen [4-OHT], or  -irradiation), the
cells were fixed with 3.7% formaldehyde and permeabi-
lized with 0.5% Triton X-100. After blocking with 1%
BSA, the cells were incubated with the indicated primary
and secondary antibodies. The nuclei were stained with
4′,6-diamidino-2-phenylindole (DAPI) (Sigma). Coverslips
were mounted using Vectashield mounting medium (Vec-
tor Labs), and images were acquired using a confocal (LSM
710, Carl Zeiss, Oberkochen, Germany) or fluorescence mi-
croscope (Eclipse Ti-S, Nikon Instruments Inc.).
Immunoprecipitation
The 293T cells that had been pretreated with or without
10 or 20 M ATM inhibitor (KU55933 from Santa Cruz)
for 1 h and then treated with 50 M etoposide or vehicle
(dimethyl sulfoxide (DMSO)) were lysed with NETN buffer
(0.1 mM dithiothreitol (DTT), 1% NP-40, 150 mM NaCl,
40 mMTris-HCl, pH 8.0) containing protease inhibitors on
ice for 10 min. The cell lysates were clarified by centrifuga-
tion and incubated with nuclease digestion buffer (0.25 M
sucrose, 1.5 mM Tris-HCl [pH 7.4], 80 mM NaCl, 3 mM
KCl, 7.5 mM NaCl, 1 mM CaCl2, 0.1 mM DTT, 20 U/ml
micrococcal nuclease) containing protease inhibitor with or
without 150U/mlBenzonase® (Sigma) or 0.1g/l ethid-
ium bromide (Qbiogene) for 15 min at 37◦C. After cen-
trifugation, the chromatin-bound proteins were collected
and incubated with antibody against the indicated proteins
for 12 h at 4◦C, and then with protein A beads for 1 h at
4◦C. The beads were then washed with NETN buffer three
times and analyzed by IB. For tagged-protein IP, 293T cells
treated with etoposide or vehicle were lysed in IP buffer (40
mM Tris-HCl [pH 7.4], 150 mMNaCl, 2 mMMgCl2, 0.2%
Nonidet P-40, 0.4% Triton X-100) containing protease in-
hibitors on ice for 30 min. The cell lysates were clarified by
centrifugation and incubated with the indicated antibody
for 12 h at 4◦C, followed by incubation with protein A beads
for 1 h at 4◦C. The precipitates were rinsed with wash buffer
(20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.2% Triton
X-100) three times, and the bound proteins were resolved
by SDS-PAGE and immunoblotted with the indicated anti-
bodies.
ChIP assay
AsiSI-ER-U2OS cells (12) were treated with 300 nM 4-
OHT (Sigma) for 4 h to induce AsiSI-ER nuclear local-
ization and DSB generation by the AsiSI nuclease. FokI-
U2OS reporter cells (13) expressing inducible ER-mCherry-
LacI-FokI-DDwere treatedwith 300 nM4-OHTplus 1M
Shield-I (Clontech) for 4 h to induce nuclear expression and
stabilization of ER-mCherry-LacI-FokI-DD andDSB gen-
eration at the transgene-harboring Lac operator sequences
by the FokI nuclease. Subsequently, ChIP was carried out
using the EZ-ChIP Kit according to the manufacturer’s
protocols (Millipore). The immunoprecipitated and input
DNAwere analyzed by quantitative PCR (qPCR) using the
Rotor-Gene SYBR® Green PCR kit (Qiagen) on a Rotor-
Gene Q system (Qiagen). The PCR conditions were an ini-
tial preincubation step at 95◦C for 5 min followed by 45 cy-
cles of 95◦C for 5 s and 60◦C for 30 s. The last amplification
cycle was followed by a melting curve analysis to confirm
the specificity of the PCR amplification. Relative IP values
were calculated based on the threshold cycle (Ct) value us-
ing the 2−Ct method (16). The sequences of the primers
used for qPCR are described in Supplementary Table S3.
HR, canonical and alternative NHEJ, and single-strand an-
nealing (SSA) DNA repair assays
HR and NHEJ efficiencies were measured by using H1299
(human non-small cell lung carcinoma cell line)-based re-
pair reporter cell lines (H1299.GC for HR and H1299.EJ
for canonical NHEJ) (15) and U2OS-based repair re-
porter cell lines (DR-GFP for HR, EJ5-GFP for canoni-
cal NHEJ, EJ2-GFP for alternative NHEJ, and SA-GFP
for single-strand annealing) (14), respectively. H1299.GC
and H1299.EJ cells were transfected with CTCF-targeting
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shRNAs. U2OS DR-GFP, EJ2-GFP, EJ5-GFP and SA-
GFP cells were transfected with siRNA targeting the 3′-
UTR of CTCF. The following day, I-SceI and HA-CTCF
constructs were transfected into each reporter cell line, and
evaluated 48 h later for GFP-positive cells using the FAC-
SAria III (BD Biosciences, San Jose, CA, USA).
Measurement of DNA end resection
Genomic DNA was extracted with a gDNA extraction kit
protocol (Dneasy blood & Tissue Kit, Qiagen) from AsiSI-
ER-U2OS cells transfected with the indicated siRNAs and
HA-tagged CTCF constructs. The DNA was then digested
with restriction enzymes (HindIII for a negative control
and BamHI (chromosome1:89,458,296; CCBL2 gene) or
BsgI (chromosome 1:110,319,090) formeasuring resection).
The level of ssDNAs generated by DNA end resection at
the specific AsiSI sites (DSBs) was evaluated by qPCR us-
ing the primer sets shown in Supplementary Table S4. The
percentage of ssDNA (ssDNA%) generated by resection at
the DSBs was determined as previously described (17,18).
Briefly, for each sample, a Ct value was calculated by sub-
tracting the Ct value of the mock-digested sample from the
Ct value of the digested sample. The ssDNA% was calcu-
lated with the following equation: ssDNA% = 1/(2(Ct − 1)
+ 0.5) × 100 (19).
siRNAs
siRNA duplexes with the following sequences were synthe-
sized byGenolution, Inc. (Seoul, Korea): CTCF, 5′-GUAG
AAGUCAGCAAAUUAAUU-3′; 3′-UTR of CTCF, 5′-
GCUGUCUGAUGUUAGCAAAUU-3′; CtIP, 5′-GAAG
GAUGAAGGACAGUUUUU-3′. Cells were transfected
with 20 nM siRNA using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions.
Immunoblotting
Immunoblotting experiments were performed as previously
described (20). Representative results from at least three in-
dependent experiments are shown in the figures.
Cellular fractionation
Cellular fractionation was performed as described previ-
ously with slight modifications (21). Briefly, the cells were
washed twice with ice-cold PBS and harvested. The cell
pellets were resuspended for 15 min on ice in 200 l ex-
traction buffer [50 mM HEPES (pH 7.5), 150 mM NaCl,
1 mM EDTA] containing 0.1% Triton X-100 and supple-
mented with protease inhibitor cocktail and phosphatase
inhibitors. Following centrifugation at 13,000 rpm (16,000
g) for 5 min, the supernatant was collected (S1 fraction).
The pellets were further extracted for 15 min on ice using
the same buffer and then collected. The pellets were further
incubated in 200 l of extraction buffer supplemented with
200 g/ml RNase A but without Triton X-100 for 30 min
at 25◦C. Following centrifugation at 13,000 rpm (16,000 g)
for 5 min, the supernatant was separated from the pellet.
The pellets were resuspended in 1% SDS-containing PBS,
boiled for 10 min and sonicated for 10 s (Ultrasonic Pro-
cessor, Cole-Parmer, Canada) (P2 fraction). The cellular
fractions were used for IB with antibodies against CTCF
(1:5000), CtIP (1:1000), phospho-RPA (S4/S8) (1:1000),
phospho-RPA (T21) (1:1000),  -H2AX (S129) (1:2000) and
-tubulin (1:5000).
Clonogenic cell survival assay
HeLa cells were seeded into 6-well plates (2× 104 cells/well)
and allowed to adhere for 24 h prior to treatment. The cells
were treated with 2 mM thymidine for 16 h, and then in-
cubated in fresh media for 6 h, followed by treatment with
0, 2 or 5 M etoposide for 1 h. After incubation for 24 h,
the cells were seeded into 60-mm plates. After 10–14 days of
incubation, the colonies were fixed with ice-cold methanol
and stained with 0.4% Crystal Violet in 20% ethanol. Sur-
vival curves were plotted after normalizing for the plating
efficiency mediated by CTCF silencing or overexpression.
The clonogenic survival curves were constructed from at
least three independent experiments.
RNA isolation and quantitative reverse transcription PCR
(qRT-PCR)
Total RNA was isolated using the Hybrid-R Total RNA
Purification Kit (GeneAll, Seoul, Korea). One microgram
of total RNA was reverse-transcribed with PrimeScript RT
Master Mix (Takara Bio, Shiga, Japan). After a 1:10 di-
lution, 2 l of cDNA was used as a template in a 20 l
PCR mixture. The following primers were used for qPCR:
CCBL2 (5′-GCCCAACAACACCAGCTCCT-3′ and 5′-
CCTGGGCATCCTTGAGTTCC-3′); GAPDH (5′-AGCC
ACATCGCTCAGACAC-3′ and 5′-GCCCAATACGAC
CAAATCC-3′). Relative quantification of gene expression
was carried out using the Ct method with GAPDH as a
reference gene. The PCR program was as follows: initial de-
naturation at 95◦C for 2 min, followed by 45 cycles of 95◦C
for 5 s and 60◦C for 30 s. The final amplification cycle was
followed by a melting curve analysis to confirm the speci-
ficity of the PCR amplification.
Statistical analysis
All data are expressed as means ± standard deviation (SD)
of at least three replicates. The Student’s t-test was employed
to analyze significant differences between datasets. Differ-
ences were considered statistically significant at P ≤ 0.05
(in figures: *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001).
RESULTS
CTCF interacts with MRE11 upon DNA damage
CTCF was recently shown to contribute to genomic in-
tegrity by facilitating HR (10,11). To clarify the role of
CTCF in HR repair and its underlying mechanism, we an-
alyzed proteins captured by co-immunoprecipitation (Co-
IP) with SFB-tagged CTCF by a proteomics approach us-
ing 293T cells expressing SFB-tagged CTCF before and af-
ter  -irradiation. Previously known CTCF-associated pro-
teins, including PARP1 (22), YBX1 (23) and nucleolin
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(24,25), were co-immunoprecipitated either with or without
 -irradiation (Figure 1A). Interestingly, we also identified
MRE11, a well-characterized component of the MRE11–
RAD50–NBS1 (MRN) complex, as a CTCF-associated
protein in a  -irradiation-dependent manner. This associ-
ation occurred even if the number of unique peptides or to-
tal spectrum count of CTCF in the presence of  -irradiation
was relatively lower than that in the absence of  -irradiation
(Figure 1A). Since only one unique peptide of MRE11A
was observed, we needed to verify this DNA damage-
responsive interaction. Thus, we performed forward and re-
ciprocal Co-IP experiments with an antibody against CTCF
orMRE11 using 293T cells with or without etoposide treat-
ment. As shown inFigure 1B andC, endogenousCTCFand
MRE11 interacted upon etoposide treatment, while they
did not associate in the absence of treatment. This result
suggests that the CTCF–MRE11 interaction occurred upon
DNA damage, or was otherwise enhanced by DNA dam-
age. Furthermore, an endogenous CTCF–MRE11 interac-
tion was observed in chromatin fractions (Figure 1B and
C; Supplementary Figure S1A), indicating that the CTCF–
MRE11 interaction was likely to occur in chromatin-bound
settings. We performed the Co-IP experiment in the pres-
ence of DNase or ethidium bromide, demonstrating that
the CTCF–MRE11 interaction was not bridged by DNA
and that the two proteins directly interacted (Supplemen-
tary Figure S1B). Taken together, the CTCF–MRE11 Co-
IP results indicate that CTCF interacts with MRE11 in a
chromatin-bound setting in response to DNA damage.
MRE11 is known to form the MRN complex with
RAD50 and NBS1. By the Co-IP assay, we found that
CTCF associated with RAD50 in the presence of etopo-
side, similar to that observed with MRE11 (Figure 1B and
Supplementary Figure S1C). The CTCF–NBS1 interaction
was augmented by etoposide treatment, although CTCF
did bind to NBS1 without etoposide (Figure 1B). We next
assessed whether ATM-mediated DNA damage signaling
pathway is engaged in the DNA damage-induced interac-
tion between CTCF and MRE11. By using an ATM in-
hibitor KU-55933, we found that etoposide-induced CTCF
interaction with MRE11 (Figure 1A–C and Supplemen-
tary Figure S1) was abolished by the ATM inhibitor (Sup-
plementary Figure S1D), suggesting that ATM-mediated
DNA damage signaling pathway may regulate the CTCF–
MRE11 interaction in response to DNA damage.
To identify the regions of CTCF that were responsible
for the CTCF–MRE11 interaction, we generated truncated
fragments of CTCF (Figure 1D). Anomalously, both N-
(residues 1–267) and C-terminal (residues 578–727) frag-
ments migrated slowly on SDS-PAGE (Figure 1D). In con-
trast, its ZF fragment (residues 246–588) appeared to mi-
grate expectedly (Figure 1D). TheN-terminus was observed
at ∼64 kDa instead of 31 kDa as predicted; the C-terminus
was observed at ∼37 kDa instead of 17 kDa as expected
(Figure 1D and Supplementary Table S5). Consistent with
this, similar aberrant mobility of bacterially purifiedN- and
C-terminal fragments of CTCF on SDS-PAGE has been
observed and reported previously (26), wherein they found
that both terminal regions are extendend, monomeric and
unstructured, and thereby migrate slowly. Accordingly, the
anomalous mobility of N- and C-terminal fragments could
be caused by their intrinsically disordered structure. En-
dogenous MRE11 pulled down full-length CTCF and frag-
ments harboring either the N-terminus or ZF (Figure 1D).
Considering the protein expression levels of the N-terminal
and ZF fragments, the N-terminus alone was likely to be
associated less with MRE11 than the ZF alone. By con-
trast, the C-terminus alone could not interact withMRE11.
The N-terminal + Zinc finger (N-ZF) fragment associated
more strongly withMRE11 than theN-terminal or ZF frag-
ment alone (Figure 1D), indicating that the combined N-
ZF fragment can associate additively or synergistically with
MRE11. The Zn finger + C-terminal (ZF-C) fragment ap-
peared to be associated less with MRE11 than with ZF
(Figure 1D). Collectively, this result indicates that the N-
terminal and ZF domain are marginally and robustly re-
sponsible, respectively, for the CTCF–MRE11 interaction,
while the C-terminus is dispensable. Similarly, we gener-
ated three fragment mutants of MRE11 (Figure 1E). The
CTCF-interacting region of MRE11 was mapped to the N-
terminus of MRE11 (residues 1–537), which harbors its nu-
clease activity as well as the NBS1- and RAD50-interacting
regions (27,28). However, the glycine-arginine rich (GAR)
motif and C-terminus of MRE11 was not required for its
CTCF interaction (Figure 1E).
Because endogenous CTCF associated with MRE11 in
chromatin fractions (Figure 1B and C) through its N-
terminal or ZF domain but not its C-terminus (Figure 1D),
we next examined whether the N-terminal and ZF domains
of CTCF bind to chromatin, andwhether its C-terminal do-
main does not bind to chromatin, in the presence or absence
of etoposide treatment. The C-terminus of CTCF was un-
detectable in chromatin fractions, its ZF domain was de-
tectable in chromatin but not in soluble fractions, and its
N-terminus was detectable in both fractions (Supplemen-
tary Figure S2). This indicates that the C-terminal domain
fails to bind to chromatin regardless of etoposide treat-
ment, contrary to the chromatin-binding capacity of the
N-terminal and ZF domains. These observations suggest
that CTCF bound to chromatin is capable of interacting
with MRE11, due to the correlation between chromatin-
binding abilities (Supplementary Figure S2) and MRE11–
interaction strengths (Figure 1D) of the N-terminal and ZF
domains of CTCF. Collectively, the CTCF–MRE11 inter-
action results support the hypothesis that CTCF associates
with MRE11 in a chromatin-bound setting in response to
DNA damage.
CTCF enrichment at sites of DNA damage depends on
MRE11
Most proteins involved in the DNA damage response, in-
cluding MRE11, localize to DNA lesions and form re-
pair foci. However, we did not observe CTCF foci by im-
munofluorescence staining following DNA damage. Using
a live, laser micro-irradiation system, we observed that, sim-
ilar to that of MRE11, CTCF was rapidly recruited to
laser strips (Figure 2A). Furthermore, we tested the CTCF
recruitment and its co-localization with MRE11 at DNA
DSBs by using the previously described FokI–U2OS re-
porter system (a U2OS clone carrying repeats of the Lac
operator in one locus of the genome), inwhich themCherry-
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Figure 1. CTCF interacts with MRE11 in response to DNA damage. (A) Selected protein list obtained from LC-MS/MS analysis after interactome
tandem affinity purification of FLAG-SFB-tagged CTCF with or without  -irradiation. The previously known and novel hits fromMS results are shown.
(B and C) Forward (B) and reciprocal (C) co-immunoprecipitation (co-IP) between endogenous CTCF and MRE11 in 293T cells, after the addition
of DNase Benzonase, was performed with anti-CTCF (B) or anti-MRE11 (C) antibody, without (left, DMSO) and with (right, Etoposide) etoposide
treatment. Immunoblot (IB) analysis was performed with the indicated antibodies. IgG immunoprecipitation (IP) was used as a negative control. See
also Supplementary Figure S1. (D and E) Schematic representations of CTCF (D) and MRE11 (E) constructs used in this study (Top). The 293T cells
were transfected with the indicated HA-tagged CTCF truncation constructs (D) or GFP-tagged MRE11 truncation constructs (E). Cell lysates were
immunoprecipitated with anti-MRE11 (D) or anti-GFP (E) antibody, and immunoblot (IB) analyses were performed with the indicated antibodies. (D)
Positions of molecular weight makers are denoted on the left of the INPUT SDS-PAGE gel. The interaction strengths between MRE11-HA and fusion
CTCF proteins were normalized to the expression levels of HA fusion CTCF proteins, i.e. input. The interaction strength betweenMRE11-HA full-length
CTCF was set as one, and the interaction strength of each HA fusion CTCF protein was calculated (bottom right panel); PAR, poly ADP-ribosylation;
NLS, nuclear localization signal; N+GAR, N-terminus and glycine arginine rich motif.
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Figure 2. MRE11-dependent recruitment of CTCF at sites of DNA damage. (A) MRE11-depleted (shMRE11) or control (shCTL) U2OS cells were
presensitized with BrdU and subjected to laser micro-irradiation. Cells were fixed and stained with the indicated antibodies; scale bar: 10 m. (B) Im-
munofluorescence was performed 4 h after induction of double-strand breaks by ER-mCherry-lacR-FokI-DD in the FokI-U2OS reporter cells transfected
with shRNA targeting MRE11 (shMRE11) or control shRNA (shCTL); scale bar: 10 m. The plot represents the percentage of cells positive for CTCF
co-localized at mCherry-FokI foci. Data are the means± SD of three independent experiments.More than 100 cells were counted in each experiment; *P≤
0.05. (C) ChIP-qPCR was performed with an antibody to  -H2AX or CTCF in the FokI-U2OS DSB reporter cells transfected with the indicated shRNA
(shCTL as a control or shMRE11 targeting MRE11), with (+) or without (−) induction of DSBs by mCherry-LacI-FokI. The values of recruitment to
DSBs were relative to those of cells without the induction of DSBs. All qPCR reactions were performed in triplicate, with the SEM values calculated
from at least three independent experiments; *P ≤ 0.05; ***P ≤ 0.001. (D) AsiSI-ER-U2OS cells were transfected with the indicated shRNA, with (+)
or without (−) induction of DSBs by AsiSI. CTCF and chromatin were immunoprecipitated with anti-CTCF antibody. The fold enrichment values were
relative to those of cells without induction of DSBs. Primers on chromosome 22 (no DSB) were used as negative controls. Data are the means ± SD of at
least three independent experiments, and all qPCR reactions were performed in triplicate. (E) Immunofluorescence was performed 4 h after induction of
double-strand breaks (DSBs) by mCherry-LacI-FokI in the CTCF-depleted (shCTCF) or control (shCTL) FokI-U2OS cells; scale bar: 10 m. Bar graph
represents the percentage of cells positive forMRE11 co-localized at mCherry-LacI-FokI foci. Data are the means± SD of three independent experiments.
More than 100 cells were counted in each experiment. ns, not significant. (F) Recruitment of MRE11 (green) to DSBs induced by laser micro-irradiation
in the CTCF-depleted (shCTCF) and control (shCTL) U2OS cells; scale bar: 10 m. (G) ChIP-qPCR was performed with an antibody to  -H2AX or
MRE11 in FokI-U2OS cells (left and center), and AsiSI-ER-U2OS cells (right) transfected with the control (shCTL) or CTCF shRNA (shCTCF), with
(+) or without (−) induction of DSBs by FokI (FokI-U2OS) or AsiSI (AsiSI-ER-U2OS). The fold enrichment values were relative to those of cells without
induction of DSBs. Data are presented as means± SD of three independent experiments, and all qPCR reactions were performed in triplicate; **P≤ 0.01;
***P ≤ 0.001.
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LacI-FokI endonuclease fusion protein introduces a sin-
gle DSB in the genome (13). Consistent with the recruit-
ment andMRE11-colocalization of CTCFonto laser strips,
CTCF was recruited and co-localized with MRE11 at the
FokI-induced DSB site (Figure 2B). As shown in Figure
2C, CTCF ChIP analysis revealed that CTCF was recruited
to the FokI-induced DNA damage site, similar to the re-
cruitment of H2AX. In the FokI–U2OS reporter system,
the mCherry-LacI-FokI nuclease results in a single DSB in
the cell. Therefore, it is possible that CTCF accumulated
at a single or a few local DSBs rather than multiple DSB
sites. To rule out this possibility, we employed an additional
AsiSI-ER-U2OS reporter system (12), in which the AsiSI
nuclease cuts multiple AsiSI sites throughout the genome
of a cell. Consistent with the recruitment of CTCF onto the
FokI-induced DSB, CTCF was readily recruited to AsiSI-
induced DSBs (Figure 2D). Altogether, these observations
indicate that CTCF accumulates at DSBs and co-localizes
with MRE11.
Given that CTCF interacted with MRE11 of the DNA
damage sensor MRN complex upon DNA damage (Figure
1), and both CTCF and MRE11 were rapidly recruited to
sites of damaged DNA (Figure 2), we investigated whether
CTCF andMRE11 could affect each other’s recruitment to
DNA damage sites. Depletion of MRE11 abolished CTCF
recruitment to the laser-induced DNA damage sites, com-
pared with that in control cells (Figure 2A). Consistent
with the CTCF recruitment in the laser strips, in the cellu-
lar system carrying the mCherry-LacI-FokI reporter (FokI-
U2OS), CTCF localization at DSBs was dramatically re-
duced upon MRE11 knockdown (Figure 2B). In a sim-
ilar manner, CTCF ChIP results using FokI-U2OS (Fig-
ure 2C) and AsiSI-ER-U2OS (Figure 2D) reporter systems
revealed that CTCF was recruited to the FokI- or AsiSI-
inducedDSBs significantly less inMRE11 knockdown cells
than in control cells. However, depletion of CTCF had little
effect on the recruitment of MRE11 to the FokI-induced
DSBs (Figure 2E) as well as the laser strips (Figure 2F).
In parallel, we found that CTCF depletion did not alter
MRE11 accumulation at both mCherry-LacI-FokI- and
AsiSI-inducedDSBs byMRE11ChIP analysis (Figure 2G).
Together, these results indicate that the accumulation of
CTCF to sites of damaged DNA requires MRE11, but not
vice versa.
Because the recruitment of CTCF onto DNA damage
sites was dependent on MRE11 (Figure 2), we investigated
whether the MRE11–CTCF interaction was indeed impli-
cated in the MRE11-mediated CTCF recruitment. Accord-
ingly, we assessed the recruitment of ectopically overex-
pressed GFP-tagged full-length or truncated CTCF onto
sites of DNA damage. As expected, we observed that GFP-
tagged full-length CTCFwas recruited to laser strips within
seconds of the laser micro-irradiation (Figure 3A). GFP-
tagged CTCF fragments harboring the N-terminal or ZF
domain, which are able to interact withMRE11 with differ-
ing strengths (Figure 1D), were recruited in the laser strips
(Figure 3A). The efficiency of CTCF fragment recruitment
onto the laser strips was variable (Figure 3A) and appeared
to correlate with the strength of interaction with MRE11
(Figure 1D). For example, the N-ZF and ZF fragments
showed rapid and strong recruitment, while the N-terminal
and ZF-C fragments showed weak but detectable recruit-
ment. In contrast, the C-terminal fragment of CTCF, which
did not interact with MRE11, failed to accumulate onto
the laser strips (Figure 3A). This micro-irradiation result in-
dicates that the CTCF–MRE11 interaction is required for
CTCF recruitment to sites ofDNAdamage. To confirm this
result, wemonitored the recruitment ofMRE11-interacting
and non-interacting CTCF fragments in the FokI-U2OS re-
porter system by fluorescence microscopy. Consistent with
the micro-irradiation result, the MRE11-interacting CTCF
fragments (i.e. N-terminal, ZF, N-ZF and ZF-C) could be
recruited at DSBs with different efficiencies, while recruit-
ment of the C-terminal fragment did not occur (Figure 3B).
The above results indicate that CTCF is recruited to sites
ofDNAdamage in anMRE11-interaction-dependentman-
ner.
CTCF is required for CtIP localization to sites of DNA dam-
age
Since CTCF interacted with MRE11 (Figure 1), which co-
operates with CtIP in HR (29), we hypothesized that CTCF
would promote recruitment of CtIP at DNA lesions. Thus,
we tested whether CTCF could affect CtIP recruitment
to DNA lesions. We monitored CtIP recruitment at FokI-
induced DSBs using the FokI–U2OS reporter system (Fig-
ure 4A) in CTCF-depleted cells. We found that CTCF de-
pletion dramatically abrogated CtIP focus formation (Fig-
ure 4A), suggesting that CTCF is required for CtIP re-
cruitment to sites of DNA damage. Next, we monitored
CtIP recruitment in laser strips in the CTCF-knockdown
cells. CTCF depletion profoundly attenuated CtIP recruit-
ment in the laser strips (Figure 4B), similar to the defective
CtIP recruitment with MRE11 depletion (Supplementary
Figure S3A). To confirm this result, we examined whether
CTCF depletion affected CtIP accumulation at DNA dam-
age sites using a ChIP assay. In CTCF-depleted cells, CtIP
accumulation onto FokI-induced or AsiSI-induced DSBs
in the FokI–U2OS and AsiSI–ER-U2OS reporter cells, re-
spectively, was dramatically reduced (Figure 4C), support-
ing the hypothesis that CtIP recruitment atDNA lesions de-
pends on CTCF. In contrast, depletion of CtIP had little ef-
fect on CTCF orMRE11 recruitment to sites of DNAdam-
age (Supplementary Figure S3B). These observations sug-
gest that CtIP recruitment to DNA damage sites requires
CTCF, but CtIP does not affect CTCF localization at these
sites.
Because CTCF was required for CtIP recruitment at
DNA lesions (Figure 4A–C), we investigated whether
CTCF could interact with CtIP. CTCFwas capable of asso-
ciating with CtIP in the presence or absence of DNA dam-
age and the CTCF–CtIP interaction was enhanced in the
presence of DNA damage (Figure 4D). We then mapped
the regions of CTCF responsible for its interaction with
CtIP. HA-tagged full-length CTCF and its fragments con-
taining ZF domains (i.e. ZF, N-ZF and ZF-C) pulled down
endogenous CtIP (Figure 4E). In contrast, CtIP was barely
detected in theN- andC-terminal immunoprecipitates (Fig-
ure 4E). Therefore, we found that the ZF domain of CTCF
was necessary for the CTCF–CtIP interaction.
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Figure 3. CTCF recruitment to DNA lesions requires its N-terminal or zinc-finger domain. (A) U2OS cells were transfected with GFP-tagged full-length
CTCF and its truncation constructs (see Figure 1D, top), and were subjected to laser micro-irradiation for up to 180 s. (B) Recruitment of the indicated
GFP-tagged CTCF proteins (green; see Figure 1D top) to double-strand breaks induced by mCherry-LacI-FokI (red) in the endogenous CTCF-depleted
(siCTCF) or control (siCTL) FokI-U2OS cells. The ectopically complemented C-terminal domain of CTCF in CTCF knockdown cells (GFP-tagged C
and ZF-C in siCTCF cells, right) is also recognized with an antibody to endogenous CTCF (blue); scale bar: 10 m.
Our results so far have established that CTCF interacts
with CtIP through its ZF domain, and depletion of CTCF
abrogates CtIP recruitment at sites of damagedDNA.Next,
we tested whether the CTCF–CtIP interaction was required
for the CTCF-mediated CtIP recruitment to DSBs. We co-
transfected cells with siRNA targeting the 3′-UTR of en-
dogenous CTCF and with full-length CTCF or its trun-
cated mutants. Using the FokI-U2OS DSB reporter sys-
tem with fluorescence microscopy (Supplementary Figure
S4A) and the ChIP assay (Figure 5A), CtIP was found to
be recruited to FokI-induced DSBs in endogenous CTCF-
depleted cells expressing exogenous, full-length CTCF or its
fragments containing the ZF region (Supplementary Fig-
ure S4A). We found that the ZF, N-ZF and ZF-C domains,
which are capable of associating with CtIP, restored the im-
paired CtIP recruitment into DSBs, indicating that the ZF
domain of CTCF is sufficient for CtIP recruitment toDSBs.
By contrast, the N- and C-terminal fragments did not res-
cue CTCF-depleted cells from impaired CtIP recruitment
to FokI-induced DSBs. Consistently, ChIP analysis showed
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Figure 4. CTCF is required for CtIP recruitment at DNA lesions. (A) Immunofluorescence was performed 4 h after induction of double-strand breaks
(DSBs) bymCherry-LacI-FokI in CTCF-depleted (shCTCF) or control (shCTL) FokI-U2OS cells; scale bar: 10m. Bar graph represents the percentage of
cells with CtIP (green) that co-localized at mCherry-FokI (red) foci. Data are themeans± SD of at least three independent experiments.More than 100 cells
were counted in each experiment; *P≤ 0.05. (B) CTCF-depleted (shCTCF) or control (shCTL) U2OS cells were subjected to laser micro-irradiation. Cells
were fixed and stainedwith the indicated antibodies. The scale bar represents 10m. (C) ChIP-qPCRwas performedwith an antibody toCtIP and  -H2AX
in the CTCF-depleted (shCTCF) or control (shCTL) FokI-U2OS cells (left) and AsiSI-ER-U2OS cells (right), with (+) or without (−) induction of DSBs.
The fold enrichment values were relative to those of cells without induction of DSBs. Data are means ± SD of at least three independent experiments, and
all qPCR reactions were performed in triplicate; *P ≤ 0.05; ***P ≤ 0.001. (D) CTCF interacts with CtIP. Co-immunoprecipitation assays were performed
using control IgG and anti-CTCF with (+) or without (−) etoposide (Eto) treatment, and the immunoprecipitates were probed for the indicated proteins
by western blotting (IB). (E) CTCF interacts with CtIP via its zinc finger domain. HA-tagged full-length CTCF and its truncated fragments (see Figure
1D, top) were expressed in 293T cells. HA-immunoprecipitates were resolved by SDS-PAGE, and blots were probed for HA (bottom) and CtIP (top).
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Figure 5. CtIP recruitment to DNA damage requires interactions with the zinc finger domain of CTCF. (A) Recruitment of CtIP to mCherry-LacI-FokI-
induced DSBs was evaluated by ChIP–qPCR in the CTCF-depleted FokI–U2OS cells complemented by the indicated HA fusion CTCF proteins (see
Figure 1D, top). CtIP and chromatin were immunoprecipitated with an anti-CtIP antibody. qPCR was performed for the quantitative analysis of ChIP
samples. Fold recruitment values were relative to those of cells without induction of DSBs. Data are means± SD of at least three independent experiments,
and all qPCR reactions were performed in triplicate; *P ≤ 0.05. (B) GFP–CtIP co-localization (green) at H2AX foci (red) in CTCF-depleted U2OS cells
complemented by the indicatedHA fusionCTCFproteins (see Figure 1D, top). CTCF-depleted (siCTCF) and control (siCTL)U2OS cells were subjected to
laser micro-irradiation. Cells were fixed and stained with the antibodies indicated on the left. The scale bar represents 10 m. (C) Co-immunoprecipitation
of endogenous CtIP and MRE11 in CTCF-depleted (+) or control (−) 293T cells was performed with anti-CtIP antibody. Immunoblot (IB) analysis was
performed with the antibodies indicated on the right.
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that CTCF fragments carrying the ZF domain restored
CtIP recruitment to DSBs in CTCF-depleted cells, compa-
rably to full-length CTCF (Figure 5A). In contrast, the N-
and C-terminal fragments did not rescue CTCF-depleted
cells from impaired CtIP recruitment to DSBs. These re-
sults suggest that the CTCF–CtIP interaction is necessary
for CtIP recruitment to DSBs.
To confirm this result further, we determined whether the
zinc finger domain of CTCF was required and sufficient for
CtIP recruitment in the laser strips. CTCF depletion abol-
ished CtIP recruitment to the  -H2AX laser line, indicative
of DNA lesions, although formation of the  -H2AX strip
was not affected by CTCF deficiency (Figure 5B). Con-
sistent with the results using the U2OS-DSB-reporter sys-
temwith FokI (Figure 5A and Supplementary Figure S4A),
full-length CTCF or its fragments harboring the ZF do-
main restored CtIP localization at the  -H2AX strips in
the CTCF-depleted cells (Figure 5B). By contrast, the N-
and C-terminal fragments did not rescue the localization of
CtIP at the  -H2AX strips (Figure 5B). That CtIP was re-
cruited to the  -H2AX strip in the presence of its full-length
or ZF-fragment form verified the significance of CTCF and
its ZF (Figure 5B). These results indicate that the CtIP-
interacting ZF domain of CTCF is necessary and sufficient
for CtIP recruitment atDSBs, in agreement with theU2OS–
DSB reporter results.
Considering that the MRN complex interacts with CtIP,
we questioned why CtIP required CTCF for its enrichment
at DNA lesions, and how CTCF contributed to CtIP ac-
cumulation at DSBs. To address this, we first investigated
whether CTCF contributes to CtIP interaction with the
MRN complex. Accordingly, we examined the interaction
of CtIP proteins with the MRN by immunoprecipitating
CtIP with or without CTCF depletion, and we found that
less MRN co-immunoprecipitated with CtIP from extracts
of CTCF-depleted cells (Figure 5C). This result suggests
that CTCF assists CtIP interaction with the MRN com-
plex, which in turn results in enhanced recruitment of CtIP
along with CTCF at DNA lesions. Based on the findings
that CTCF is dependent on MRE11 for its DSB recruit-
ment (Figure 2A–D) and is required for CtIP enrichment
at DNA lesions (Figure 4A–C) through DNA damage-
promotedCTCF–MRN/CTCF–CtIP interactions (Figures
1 and 4D) and the CTCF-assisted CtIP–MRN interaction
(Figure 5C), CtIP recruitment kinetics must correlate with
those of CTCF and its fragments if the CTCF-dependent
CtIP enrichment at DSBs is attributable to CtIP recruit-
ment. Otherwise, if the CTCF dependency is attributable to
CtIP retention, full-lengthCTCF and its fragmentsmust af-
fect the stability (such as length or extent) of CtIP residence
at DNA lesions, rather than the timing of CtIP recruitment.
To test this, we conducted time-lapse imaging analyses of
CtIP recruitment into the laser strips in CTCF-depleted
cells complemented with or without full-length CTCF or its
fragments. As shown in Figure 3A, the CTCF recruitment
to laser lines could be detected as early as 10 s after micro-
irradiation. In contrast, the CtIP recruitment to laser lines
was significantly delayed up to 60 s compared with that of
CTCF. In CTCF-knockdown cells, CtIP failed to translo-
cate to laser lines; however, reintroduction of full-length
CTCF rescued the CtIP recruitment by 60 s, which be-
camemore clearly defined over time (Supplementary Figure
S4B). The difference between the time points of CTCF (10
s, earlier) and CtIP (60 s, later) recruitment onto the laser
tracks, together with the findings that CtIP depletion did
not detectably affect CTCF accumulation at sites of dam-
aged DNA (Supplementary Figure S3B) but CTCF deple-
tion, conversely, hampered CtIP recruitment (Figure 4A–
C), raised the possibility that CTCF acts upstream of CtIP
inDNA end resection. Complementation of the N-terminal
CTCF fragment, which was weakly recruited at 10 s (Fig-
ure 3A) and was not able to interact with CtIP (Figure 4E),
failed to recruit CtIP (Supplementary Figure S4B) because
the N-terminus was not able to interact with CtIP, resulting
in no CtIP recruitment. In contrast, all CTCF fragments
harboring the ZF (i.e. ZF, N-ZF and ZF-C), which inter-
acted with bothMRE11 and CtIP (Figures 1D and 4E) and
were recruited by 10 s following micro-irradiation (Figure
3A), caused CtIP recruitment by 60 s and persistence un-
til 240 s, similar to that in the presence of full-length CTCF
(Supplementary Figure S4B). The C-terminal CTCF, which
is incapable ofDSB recruitment andCtIP interaction, failed
to recruit CtIP (Supplementary Figure S4B). These kinetic
analyses of CtIP recruitment onto laser strips (Supplemen-
tary Figure S4B) reveal that CTCF promoted CtIP recruit-
ment possibly in aCTCF–CtIP interaction-dependentman-
ner. However, these kinetic results do not exclude the pos-
sibility that CTCF also stabilizes CtIP retention instantly
after its recruitment to DNA lesions, resulting in elongated
and/or intensive retention in addition to CTCF-dependent
CtIP recruitment. This is presumably caused by CTCF in-
tensifying the CtIP–MRN interaction (Figure 5C) and in-
teracting more strongly withMRN and CtIP in response to
DNA damage (Figures 1 and 4D).
CTCF enhances CtIP-mediated DNA end resection
MRE11 cooperates with CtIP in 5′-to-3′ DSB resection, an
early step in DNA repair that controls HR initiation (29).
As our results revealed that CTCF interacts with MRE11
(Figure 1) and CtIP (Figure 4D and E), and that MRE11
is required for CTCF recruitment (Figure 2) and CTCF
is then required for CtIP recruitment to damaged DNA
sites (Figure 5), we hypothesized that CTCFwould enhance
MRE11–CtIP-mediated DNA end resection via CtIP re-
cruitment to DSBs. To test this hypothesis, we first con-
ducted a DNA end resection assay in the absence of CTCF
by using the AsiSI–ER–U2OS reporter system. We found
that CTCF knockdown remarkably reduced DNA end re-
section at the AsiSI-induced DSB on chromosome 1, posi-
tion 89,458,296 to a level similar to that achieved by deplet-
ing CtIP, the key HR cofactor for the essential catalytic en-
zyme MRE11, compared with that in cells expressing con-
trol siRNA (Figure 6A). The efficiency of DNA end resec-
tion at DSBs was similar in CtIP- and CTCF-depleted cells,
confirming the requirement of CTCF for DNA end resec-
tion. This reduction in DNA end resection was recovered
by reintroduction of the siRNA-resistant full-length CTCF
or its fragments containing the ZF domain (Figure 6A), in-
dicating that the resection is not compromised unless the
fragment containing the ZF is absent. The ZF fragment by
itself showed a modest resection recovery, compared with
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Figure 6. CTCF depletion impairs DNA end resection. (A) Quantification of ssDNA generated by 5′-end resection at three sites (left, 2-1, 2-2, and 2–3
are 364, 1754 and 3564 bp from DSB, respectively and the paired primers across BamH 1 restriction sites are indicated as black arrow pairs) around the
AsiSI-induced DSB (red) on chromosome 1:89,458,296 position in AsiSI–ER–U2OS cells transfected with the indicated shRNAs and HA-tagged CTCF
constructs (right plot). The primers (black arrow pair) on chromosome 22 (no DSB) across a Hind III restriction site were used for negative control
(left). Data are means ± SD of at least three independent experiments, and all qPCR reactions were performed in triplicate; *P ≤ 0.05, **P ≤ 0.01 (see
Supplementary Figure S13A indicating levels of depleted CTCF or CtIP and complemented HA-tagged CTCF proteins.). (B) Design of qPCR primers and
probes for measurement of resection at sites, 3-1 (180 bp), 3-2 (1213 bp) and 3-3 (2928 bp) near an AsiSI-induced DSB (red) on chromosome 1:110,319,090
position (left). Quantification of ssDNA generated from resection at three sites (left, 3-1, 3-2 and 3-3 located at Bsg I restriction sites) as in part (A) (right
plot). Data represent means ± SEM of three independent experiments (see Supplementary Figure S13B indicating levels of silenced and complemented
proteins.). (C) Accumulation of RPA onto the laser strips in CTCF-depleted U2OS cells complemented with the indicated GFP-tagged full-length or
truncated CTCF proteins (left, see Figure 1A, above). Relative fluorescent intensities of RPA to those of  -H2AX are presented in the right plot as the
means ± SD of at least three independent experiments. More than 30 cells were counted in each experiment.
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the robust resection conferred by N-ZF, but the expression
level of the ZF fragment was significantly lower than that
of N-ZF and ZF-C, possibly explaining the lower DNA re-
section recovery by the isolated fragment. However, the ex-
pression levels of N-ZF and ZF-C did not correspond pro-
portionally to their resection recovery efficiencies. This sug-
gests that the N-terminus is able to interact with MRE11
(Figure 1D) but not CtIP (Figure 4E) and plays a structural
role in coordinating MRE11 and CtIP in concert with the
ZF domain, which is able to concomitantly interact with
both MRE11 and CtIP. However, the C-terminus is unable
to interact with bothMRE11 andCtIP (Figures 1D and 4E)
and appears to be dispensable for DNA end resection. In
contrast, the N- and C-terminal fragments of CTCF with-
out the ZF domain failed to reverse the DNA end resection
defect in the CTCF-knockdown cells. The DNA end resec-
tion efficiencies of the CTCF fragments correlated with the
ability of each fragment to recruit CtIP into DSBs, indicat-
ing that CTCF facilitates CtIP recruitment at DNA lesions
and regulates the resulting DNA end resection. Next, to ex-
amine whether CTCF cooperates with CtIP in DNA end
resection during DSB repair, resection efficiencies were as-
sessed in CtIP and CTCF double-knockdown cells. The co-
depletion of CTCF and CtIP reduced end resection at the
AsiSI-induced DSBs to similar levels as observed with ei-
ther single depletion (Supplementary Figure S5A), suggest-
ing an epistatic relationship between CTCF andCtIP in end
resection at DSBs. Therefore, these results suggest an im-
portant role for CTCF in regulating DNA end resection by
recruiting CtIP at DSBs.
CTCF was robustly translocated to laser lines (Figures
2A, F and 3A) and efficiently recruited CtIP (Figures 4B
and 5B; Supplementary Figure S4B) to theDSB lines, which
were induced by laser micro-irradiation that randomly in-
troduces DNA damage to the whole genome. These ob-
servations raise the possibility that CTCF is localized to
DSBs irrespective of DNA sequence, transcriptional activ-
ity or chromatin status. Nonetheless, current evidence from
genome-wide approaches suggests that actively transcribed
regions are fragile and DSBs within actively transcribed
regions are favorable for HR rather than NHEJ by pref-
erentially accumulating HR factors (30–32). Accordingly,
the transcription factor CTCF might be localized through
its ZF DNA-binding domain to transcribed chromatin, in
whichDSBs are generated and inherentlyHR-prone. To test
these two possibilities, we first confirmed whether there are
CTCF-binding cis elements near the AsiSI-induced DSB
site at position 89,458,296 on chromosome 1. The CCBL2
gene locus is mapped to this position and, therefore, active
chromatin is possibly formed. This CCBL2 gene (chromo-
some1:89,458,296) is not a CTCF target gene, to exclude
any possibility that CTCFbinds to this active chromatin site
in advance of cleavages generated by the AsiSI-ER nuclease
(already present before DNA damage induction), without
regard to DNA damage. Through ChIP-qPCR on the site,
we confirmed the absence of CTCF under normal condi-
tions before DNA damage (Figure 2D). We further evalu-
ated the impact of CTCF depletion on transcription of the
CCBL2 gene and found that this gene was robustly tran-
scribed and its transcription was barely altered by CTCF
depletion (Supplementary Figure S6). This suggests that
CTCF hardly participates in the transcription of CCBL2
and that CTCF is indeed recruited into DSBs around active
chromatin regions of this gene in response to DNAdamage.
However, this does not exclude the possibility that CTCF
engages inDSB repair at active chromatin regions but not at
inactive chromatin regions, because HR rather than NHEJ
is chosen as the predominant repair pathway in the context
of active chromatin (30–32). Thus, CTCF in combination
with other HR components can be recruited to these tran-
scribed sites.
Hence, we employed one additional AsiSI cut site
(chromosome1:110,319,090), which is not mapped to any
gene locus, in addition to the AsiSI cut site resident at
the CCBL2 gene (chromosome1:89,458,296), previously
described above. The site was chosen in an unbiased
manner and because of the presence of restriction sites
nearby for subsequent resection experiments. We first as-
sessed DSB induced by the AsiSI-ER fusion nuclease on
this inactive chromatin belonging to no gene (chromo-
some1:110,319,090) by the enrichment of H2AX, an in-
dicator of DNA damage. We found that  -H2AX ac-
cumulated at this inactive chromatin region (chromo-
some1:110,319,090) following induction of the AsiSI-ER
nuclease. This indicates that the inducible AsiSI-ER ro-
bustly introduces DSBs into both this inactive chromatin
site (Supplementary Figure S7) and the active chromatin
site, CCBL2 (chromosome1:89,458,296). Then, we asked
whether CTCF could be recruited on the AsiSI-induced
DSBs located at this inactive chromatin and whether the ex-
istence of CTCF on the DSBs affected the level of CtIP and
DNA end resection. Similarly, CTCFwas enriched at DSBs
located in the inactive chromatin (Supplementary Figure
S7), strongly suggesting that CTCF is recruited into DSBs
at both active and inactive chromatin. Next, we examined
whether CTCF depletion influences CtIP recruitment and
consecutive DNA end resection at DSBs around inactive
chromatin regions. Similar to that of DSBs in active chro-
matin regions, CTCF depletion reduced CtIP accumula-
tion (Supplementary Figure S7) and DNA end resection ef-
ficiency at inactive chromatin regions (Figure 6B). As ex-
pected, knockdown of CtIP with or without CTCF knock-
down reduced DNA end resection efficiency in the inactive
chromatin regions to a similar level as in the single depletion
of either CTCF or CtIP (Supplementary Figure S5B). This
is consistent with the effects in active regions (Supplemen-
tary Figure S5A), supporting that CTCF functions in the
same resection process, as does CtIP. Together, these results
from the active and inactive chromatin experiments suggest
that CTCF has a critical role in CtIP recruitment and DNA
end resection without regard to chromatin status.
The cell-cycle-dependent regulatory mechanism for the
choice between canonical NHEJ (cNHEJ) and HR is im-
portant. In S/G2 phases, when sister chromatids are avail-
able for HR, MRE11–CtIP is responsible for DSB resec-
tion, which involves nucleolytic processing of DSBs to pro-
duce ssDNA tails that are required for HR (33). We there-
fore examined whether CTCF depletion affects cell cycle
distribution, and found that cell cycle distribution profiles
were comparable in control and CTCF-depleted cells (Sup-
plementary Figure S8), consistent with the findings of a pre-
vious report (11). This result suggests that CTCF-promoted
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HR is not caused by the regulation of cell cycle progression
and that CTCF promotes HR through a different mecha-
nism.
During the process of resection, RPA coats ssDNA over-
hangs and is then phosphorylated (29). To further de-
termine whether CTCF deficiency affects resection, we
treated control and CTCF-depleted cells with etoposide
and assessed RPA phosphorylation and chromatin bind-
ing. In asynchronous cells, the levels of chromatin-bound
phospho-RPA and CtIP had changed little in CTCF-
depleted cells (Supplementary Figure S9A). Thus, we eval-
uated the effects of CTCF deficiency on RPA phosphoryla-
tion and chromatin binding of CtIP in S/G2 phases. H2AX
phosphorylation ( -H2AX), which occurred independently
of DSB resection, was similar in etoposide-treated control
and CTCF-depleted cells in S/G2 phases (Supplementary
Figure S9B). However, the levels of RPA phosphorylation
andCtIP bound to chromatinwere lower inCTCF-depleted
cells in S/G2 phases compared to that in control cells (Sup-
plementary Figure S9B). In addition, RAD51 assembly at
DSBs was profoundly reduced in CTCF-depleted cells in
comparison to that in control cells (Supplementary Figure
S9C), suggesting that CTCF promoted DSB resection, and
thus leading to ssDNA generation. Thus, CTCF is able to
promote ssDNA formation competent for RPA phospho-
rylation and the chromatin binding of phospho-RPA.
To further ascertain the role of CTCF in DNA end
resection, we tested whether CTCF depletion would af-
fect DNA damage-induced RPA focus formation, since
decreased RPA phosphorylation in CTCF-depleted cells
(Supplementary Figure S9D and E) correlated with de-
creased DSB resection (Figure 6A and B). Knockdown of
endogenous CTCF diminished RPA focus formation, ei-
ther in the mCherry-LacI-FokI reporter system (Supple-
mentary Figure S9D) or after  -irradiation (Supplementary
Figure S9E). The ChIP assay using the AsiSI–ER–U2OS
reporter system confirmed that  -H2AX was enriched at
DSBs in the untranscribed (on chromosome1:110,319,090;
inactive chromatin) regions similar to that in the tran-
scribed (CCBL2 gene on chromosome1:89,458,296, active
chromatin) regions (Supplementary Figure S7), but RPA
enrichment at DSBs near both these transcribed and un-
transcribed chromatin regions was remarkably impaired in
cells depleted of endogenous CTCF (Supplementary Fig-
ure S9F). These results show that the RPA coating of ss-
DNA resulting from DNA end resection at DSBs was de-
fective in cells lacking endogenous CTCF despite the fact
that  -H2AX focus formation was not affected. Using ver-
ified, CTCF-targeted siRNA and siRNA-resistant CTCF
constructs, we further evaluated the RPA coating achieved
by full-length CTCF or its fragments in cells depleted of
endogenous CTCF. In cells lacking endogenous CTCF, ei-
ther full-length CTCF or its fragments harboring the ZF
domains were able to reverse the RPA recruitment defect
(Figure 6C). By contrast, the N- and C-terminal fragments
that failed to reverse the CtIP recruitment defect (Figure 5)
did not restore the impaired RPA recruitment in cells de-
pleted of endogenous CTCF (Figure 6C). Together, our re-
sults suggest an important role of CTCF in theDNAend re-
section step of HR by enhancing CtIP recruitment to DSBs.
Cellular role of CTCF in DNA-damage response
Our results reveal that CTCF was recruited to DNA lesions
in an MRE11-dependent fashion (Figures 1 and 2), and
that CTCF promoted CtIP recruitment, leading to DNA
end resection at DSBs (Figures 4–6). DNA end resection
catalyzed by the key HR proteins MRE11 and CtIP is es-
sential for initiation of the HR repair pathway (34). Thus,
we surmised that CTCF-mediated CtIP recruitment and
DNA end resection are required for efficient HR. To test
this supposition, we first assessed the DNA repair efficiency
of CTCF by H1299-based HR/cNHEJ repair analysis (15).
Using verified CTCF-targeted shRNA, wemeasured the re-
pair efficiency achieved by CTCF and found that CTCF de-
pletion alleviated HR but did not alter cNHEJ, revealing
that CTCF is critical for HR but does not affect cNHEJ
(Supplementary Figure S10A). To confirm this in the other
well-established U2OS-based reporter systems, we evalu-
ated HR and cNHEJ repair efficiency. CTCF-knockdown
in these systems significantly lessened HR and marginally
increased cNHEJ (Figure 7A, <10%), which is consistent
with the effects of CTCF depletion on HR but inconsis-
tent with the lack of detectable effects on cNHEJ in the
H1299-based reporter systems. This suggests that CTCF in-
deed promotesHR,while CTCF seems to have no effects (or
only subtle effects) on cNHEJ in a cell-type or cell context-
dependent manner.
Since CTCF, whose recruitment depends on MRE11
(Figure 2), was found to play a role in DNA end resection
by recruiting CtIP to DSBs (Figure 6) and CtIP-mediated
DSB resection is required for HR initiation (29), we won-
dered whether the ZF domain of CTCF, which is able to
recruit CtIP to DSBs (Figure 5) and achieve significant
DSB resection (Figure 6A and B), supports HR repair by
establishing functional HR links between MRE11, CTCF
and CtIP. To do this, we evaluated DSB repair efficiency
in CTCF-knockdown cells expressing siRNA-resistant full-
length CTCF or its fragments, using U2OS-based reporter
assays for HR and cNHEJ repair (14). As shown in Fig-
ure 7B, full-length CTCF and its fragments harboring ZF
domains efficiently restored HR, consistent with the re-
quirement of CTCF in CtIP recruitment and DSB resec-
tion, which is a key prerequisite for HR. The efficiencies
of HR rescue by the CTCF constructs were correlated with
those of the rescuedCtIP recruitment andDNA resection in
CTCF-depleted cells. Conversely, cNHEJ repair efficiency
was not affected by CTCF depletion and reintroduction
of the CTCF constructs in the U2OS-based (Supplemen-
tary Figures S10B and S11) and H1299-based (Supplemen-
tary Figure S10C) knockdown cells. These results indicate
that CTCF-mediated CtIP recruitment at DSBs is critical
for the function of CTCF in HR. Moreover, in agreement
with previous findings (34,35), we found that depletion of
CtIP resulted in a significant reduction in HR repair effi-
ciency (Supplementary Figures S10B and S11), indicating
that CTCF is required to promote HR, similar to that of
CtIP. Additionally, depletion of both CTCF and CtIP at-
tenuated HR to a level that was similar to that of either
single depletion (Supplementary Figure S10B). This further
supports the supposition that CTCF functions in the same
genetic pathway as CtIP during DSB repair, consistent with
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Figure 7. CTCF–CtIP interaction contributes to CTCF-mediated homologous recombination (HR) and survival upon exposure to DNA damage. (A)
U2OS-based homologous recombination- (DR-GFP) or canonical non-homologous end joining- (EJ5-GFP) reporter cell lines were co-transfected
with siRNA (control, siCTL, or endogenous CTCF-specific, siCTCF) and I-SceI as indicated. Homologous recombination (HR) and canonical non-
homologous end joining (cNHEJ) efficiencies were analyzed as in part (A). The plotted values are means ± SEM from at least three independent experi-
ments; *P ≤ 0.05; ***P ≤ 0.001. (B) HR reporter cells (DR-GFP) were transfected with the indicated siRNAs and HA-tagged CTCF constructs together
with I-SceI and subjected to an HR assay as in part (A) (see Supplementary Figure S13C indicating knockdown of endogenous CTCF and supplementa-
tion with the full-length or truncated constructs of CTCF.) The plotted values are means ± SEM from at least three independent experiments; *P ≤ 0.05;
**P ≤ 0.01. (C) Effect of ectopic expression of the indicated HA-tagged CTCF proteins on survival of CTCF-depleted HeLa cells after treatment with
etoposide. HeLa cells were transfected with the indicated siRNAs and HA-tagged CTCF constructs. The cells in asynchronous or S/G2 phase were treated
with etoposide, and survival fractions were confirmed by a clonogenic survival assay. The intensities and areas of the colonies were measured using ImageJ
software (see Supplementary Figure S13D showing depletion of CTCF or CtIP and supplemented CTCF protein levels.). (D) Somatic point mutations
(nonsense and missense) of CTCF from Catalogue of Somatic Mutations in Cancer (COSMIC) as of 13 October, 2018. Among them, 14 substitution mu-
tations were identified in ≥4 samples across tumors in the COSMIC database. Eight out of the 14 mutations were located on the zinc finger (ZF) domain,
which was defined as Pfam (ID P49711). As the frequency of mutations in the ZF domain of CTCF was higher than that in its N-terminal domain, the
somatic mutations were significantly enriched within the ZF domain in cancer. (E) Model for the role of CTCF in DNA end resection of HR-mediated
repair via CtIP recruitment. The MRN complex recognizes and binds to double-strand breaks (DSBs) and recruits CTCF to sites of DNA damage. In
turn, CTCF promotes the recruitment of CtIP to DSBs and enhances DNA end resection.
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the results of the DNA end resection assay. Taken together,
these results raise the possibility that CTCF and CtIP fa-
cilitate HR, whose initiation depends on DSB resection,
but they are not engaged in cNHEJ. This differs from the
key HR player, BRCA1, which promotes HR and concomi-
tantly antagonizes cNHEJ.
Unlike cNHEJ, alternative NHEJ (aNHEJ) and SSA re-
pair depend on several HR proteins, including MRN and
CtIP, like HR, these repair pathways are initiated by DSB
resection, but they do not involve homologous sister chro-
matids (36,37). Thus, we examined whether CTCF-assisted
resection at DSBs can promote aNHEJ and SSA repair. To
do this, we conducted U2OS-based aNHEJ and SSA repair
assays (14) in CTCF-depleted cells. CTCF depletion led to
>50% reductions in aNHEJ and SSA efficiencies (Supple-
mentary Figures S10B and S11), contrary to its subtle effect
on cNHEJ (Figure 7A and Supplementary Figure S10A,B).
Reintroduction of full-length CTCF or its ZF fragments
into cells depleted of endogenous CTCF rescued defective
SSA and aNHEJ, analogous to the effects on HR. These re-
sults indicate that reduced SSA and aNHEJ levels by CTCF
depletion could be caused by impaired activity of DSB re-
section. Furthermore, the efficiencies of all tested DSB re-
pair pathways (HR, SSA, aNHEJ and cNHEJ) in CTCF-
depleted cells were comparable to those in CtIP-depleted
cells (Supplementary Figure S10B), indicating a functional
similarity between CTCF and CtIP in DNA repair. Collec-
tively, these repair assay results suggest that CTCF facili-
tates HR, SSA and aNHEJ repair by recruiting CtIP and
subsequently promotingMRE11/CtIP-mediated resection.
To corroborate these findings, we assessed the relevance
of the ZF domain of CTCF, which is the CtIP-interacting
region, for CTCF-driven HR in DNA damage sensitiv-
ity. To test this, cells depleted of endogenous CTCF with
siRNAwere compared with cells expressing control siRNA
for their sensitivity to etoposide. In clonogenic cell survival
assays, exposure of the cells to etoposide reduced the via-
bility of the CTCF-depleted cells (Figure 7C). Consistent
with theHR rescue efficiency of either the full-length CTCF
or its ZF domain fragments in CTCF-depleted cells (Fig-
ure 7B and Supplementary Figure S10B), the cells exhibited
partial complementation for survival (Figure 7C). While
the CTCF-depleted and CtIP-depleted cells were equiva-
lent with regard to HR and other repair pathways (Fig-
ure 7B and Supplementary Figure S10B) as well as DNA
end resection efficiency (Figure 6A and B), there were clear
differences between the CTCF-depleted and CtIP-depleted
cells with regard to etoposide sensitivity (Figure 7C). The
CTCF-depleted cells were hypersensitive to etoposide com-
pared to that of the CtIP-depleted cells (Figure 7C). These
differential etoposide sensitivities conferred by eitherCTCF
or CtIP depletion indicate that CTCF likely contributes
to DNA damage responses in addition to DNA repair,
in which CTCF functions in concert with CtIP. This was
also supported by the etoposide sensitivity of CTCF- and
CtIP-codepleted cells, which was similar to that of CTCF-
depleted cells in asynchronized status and marginally in-
creased in S/G2 phases (Figure 7C). Together, our results
illustrate the biological importance of the interaction be-
tween MRE11–CTCF–CtIP in DNA damage response via
HR priming, and provide mechanistic evidence for a role of
CTCF in the DNA end resection step of HR by facilitating
CtIP recruitment to DSBs.
DISCUSSION
CTCF is the master genome organizer (38) identified lately
to contribute to genome integrity by participating in HR
(10, 11). Despite this importance, a definite role of CTCF
in HR and its underpinning mechanism have been largely
overlooked. This oversight has been due, in part, to a
seemingly unrelated HR function distinct from the nu-
merous, reported genome regulatory functions, such as
transcriptional activation/repression, insulation, imprint-
ing, X-chromosome inactivation and affecting 3D chro-
matin architecture. Here, we report that CTCF facilitates
HR throughDNAend resection by recruitingCtIP toDSBs
(Figure 7E). This assertion is based on our findings that de-
pletion of CTCF causes a loss of CtIP localization at DNA
lesions (Figure 4A–C), impaired DSB resection (Figure 6A
and B; Supplementary Figure S5A and B) and compro-
mised HR (Figure 7A and Supplementary Figure S10A).
Our analysis also establishes a mechanistic basis for
CTCF–MRE11–CtIP cooperation (Figure 7E). Ectopic ex-
pression of fragments harboring the ZF region of CTCF
rescued MRE11-dependent CTCF recruitment (Figure 3),
CtIP recruitment (Figure 5A and B; Supplementary Figure
S4A), DSB end resection (Figure 6A and B) and HR (Fig-
ure 7B and Supplementary Figure S10B) defects in CTCF-
depleted cells. Thus, our findings suggest that the ZF re-
gion of CTCF is necessary for the role of CTCF in HR.
CTCF interacted with CtIP through its ZF region (Fig-
ure 4E). The importance of the CTCF–CtIP interaction
for CTCF-mediated HR was also supported by the corre-
lations between the rescue efficiencies and CtIP interaction
strengths of each fragment harboring the ZF region. TheN-
terminus of CTCF assisted ZF-mediated HR processes, in-
cludingDNAend resection (Figure 6A andB) andCtIP sta-
bilization, but not recruitment (Figure 5A), considering our
finding that the N-terminal domain did not interact with
CtIP (Figure 4E and Supplementary Figure S4B). What
might be possible explanations for this auxiliary role of its
N-terminus that is not necessarily essential for the CTCF–
CtIP interaction but contributes to DNA end resection?
An appealing clue exists in the functional importance of
NBS1 in connecting CtIP to S/G2 cyclin-dependent kinase
(CDK) and ATM for CtIP phosphorylation (39) and then
linking this phosphorylated CtIP to the MRE11/RAD50
nuclease for resection (40,41). This suggests that NBS has
a structural role in bridging CtIP to stimulate the MRE11
nuclease. Likewise, the N-terminus of CTCF interacts with
MRE11 and thereby seems likely to have a structural role in
coordinatingMRE11 with CtIP, which is bound to and pre-
sented by the ZF domain. This consequently leads to more
efficient resection than with ZF alone, albeit the function-
ally minimal region of CTCF for HR is indeed the ZF do-
main. Interestingly, according to the Catalogue of Somatic
Mutations in Cancer, the most frequently mutated CTCF
nucleotides in human cancers are enriched within the ZF
domain, suggesting that its ZF domain is likely to be essen-
tial for error-free DNA repair and genome integrity (Fig-
ure 7D). Taken together, reversal of these CTCF-depletion
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defects by its ZF region is, therefore, dependent on the in-
teraction between CtIP and the ZF region of CTCF, which
likely leads to CtIP recruitment at DSBs, end resection and
HR initiation.
The CTCF-assisted end resection at DSBs seems to ap-
ply not only to HR (Figure 7A, and Supplementary Fig-
ure S10A) but also to the aNHEJ and SSA pathways (Sup-
plementary Figure S10B), which are initiated by end resec-
tion at DSBs and share the DSB resection with HR (36,37).
When assessed using aNHEJ/SSA repair reporters, knock-
downofCTCF suppressed aNHEJ and SSAand this dimin-
ished aNHEJ/SSA repair efficiency was equivalent to that
of CtIP-depleted cells (Supplementary Figure S10B), sup-
porting that CTCF contributes to end resection at DSBs
and resection-dependent repair pathways. Moreover, ad-
ditional CTCF depletion had minimal impact on defec-
tive DNA end resection and impaired HR/aNHEJ/SSA in
CtIP-depleted cells and vice versa, consistently and strongly
suggesting that CTCF and CtIP function in the same path-
way during DSB repair. The finding that CTCF and CtIP
did not engage or marginally engaged in cNHEJ (Figure 7A
and Supplementary Figure S10A–C), consistent with pre-
viously reported results that CtIP depletion does not de-
tectably increase cNHEJ in U2OS cells (34,35), is remi-
niscent of their functional connection to the resection and
resection-dependent repair pathways. The epistatic nature
of CTCF and CtIP, both single- and co-depletion, on end
resection and DSB repair pathways reinforces this notion.
By contrast, an earlier study reported that depletion of CtIP
from 293T cells modestly increased cNHEJ (1.3- to 1.4-
fold) (42), suggesting that CtIP suppresses cNHEJ in 293T
cells. Together, these contradictory effects of CtIP on cN-
HEJ suggest that cell type or cell context influences the in-
volvement of HR proteins in cNHEJ, and, if involved, their
role in cNHEJ. The major distinction between the previous
controversial results is the different cell lines used for the
studies. Thus, in our study, we employed two U2OS- and
H1299-based repair reporter systems, which have wild-type
and homozygous partial deletion mutant p53, respectively,
and regulate the cell cycle checkpoint at the G1–S transition
by directly targeting p21 transcription, the Ink41/Cip1 in-
hibitor, to arrest cells at the NHEJ-predominant G1 phase.
We therefore asked whether DNA damage-induced p21 ex-
pression is impaired in H1299 cells. Induction of p21 fol-
lowing etoposide treatment was detected in all tested repair
reporter cell lines except for H1299 (Supplementary Figure
S12), suggesting that the induced p21 activates theG1-phase
checkpoint and enhances cNHEJ efficiency in U2OS-based
repair reporter cell lines. In contrast, the defective p21 in-
duction by p53 gene deletion in H1299-based cell lines may
not contribute to increased cNHEJ efficiency. Accordingly,
this disparity between the U2OS and H1299 cell lines may
cause differences in cell-cycle arrest at G1 between them,
whichmight be advantageous (U2OS) and disadvantageous
(H1299) for cNHEJ. We can speculate that small but dif-
ferential effects of CTCF depletion and ectopic expression
of its full-length gene or truncated fragments on cNHEJ in
H1299 (no effect) or U2OS (marginal effect, <10%) cells
may be mirrored by this differential cell context. Notwith-
standing the small marginal effect of CTCF depletion on
cNHEJ inU2OS cells, CTCF can promoteHR largely with-
out interfering with cNHEJ. Our results further reveal a
functional correlation between CTCF and CtIP in end re-
section and DSB repair, as well as a functional distinction
between CTCF–CtIP and BRCA1 in antagonizing cNHEJ.
This, in turn, allows us to hypothesize that CTCF pro-
motes HR by a mechanism distinct from BRCA1′s molec-
ular role in counteracting 53BP1 by promoting 53BP1 de-
phosphorylation and releasing its essential partners, RIF1
and PTIP, which are required for end protection, from re-
section (43–46). Rather, CTCFwould promote HR by facil-
itating early steps in the HR pathway, which is essential for
HR-mediated repair, HR choice or both. Consistent with
our hypothesis, we identified the MRN complex and CtIP
as novel CTCF-interacting partners (Figures 1 and 3), both
of which control the decision to repair DSB by HR through
the regulation ofDSB end resection (47). Prompted by these
findings, we further revealed that CTCF enhancedDSB end
resection by recruiting CtIP through the CTCF–CtIP inter-
action (Figures 5 and 6).
According to an attractive hypothesis, the chromatin sta-
tus where DSBs occur is another regulatory factor for the
choice between the cNHEJ and HR pathways; indeed, ac-
tively transcribed regions favor HR associated with tran-
scription by a DNA–RNA hybrid-dependent recruitment
of RAD52, XPG and BRCA1, followed by recruitment of
RAD51 (30,32). CTCF is a transcription factor and we
found that it recruited CtIP and sequentially promoted end
resection at two AsiSI cut sites, which reside within the
CCBL2 gene (chromosome 1:89,458,296). We extended the
CTCF relevance to another AsiSI cut site (chromosome
1:110,319,090), which does not belong to any gene, in an in-
active chromatin region. We revealed that CTCF functions
in CtIP recruitment, end resection and HR independently
from transcription per se and, thus, CTCF can contendwith
DSBs at both active and inactive chromatin sites. However,
this does not exclude the possibility that CTCF participates
in transcription-associated HR (32).
BRCA1 also promotes CtIP-mediated DNA end resec-
tion via its interaction with CtIP (48). However, a previ-
ous study using a mouse model also showed that loss of the
CtIP–BRCA1 interaction has little effect on resection and
genomic integrity (49). Rather, there are additional routes
for the initiation of HR via enhancing DSB end resection,
wherein p75 (50), USP4 (51) or AUNIP (52) interacts with
CtIP, promoting CtIP accumulation at DSBs for efficient
end resection and HR. CTCF was required for CtIP ac-
cumulation at DSBs and enhanced DSB end resection and
HR (Figures 4–7). Mechanistically, CTCF functioned with
MRE11 and CtIP, critical nucleases for DSB end resection
(Figures 5 and 6), acting downstream of MRE11 (Figure 2)
and upstream of CtIP in the resection (Figures 4–6). CTCF
is required for this attribute, where CTCF-mediated CtIP
recruitment facilitates DSB end resection by the MRE11–
CtIP nuclease. Then, CTCF may recruit RAD51 via its in-
teraction to promote the formation of the RAD51 presy-
naptic filament onto a long ssDNA stretch generated from
DNA end resection in HR, as shown by our results as well
as those of a previous report (11).More importantly, CTCF
interacted with MRE11, especially in the presence of DNA
damage (Figure 1). Thus, this DNA damage-responsive as-
sociation between CTCF andMRE11 enabled CTCF to en-
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gage in theDNAdamage response. Furthermore, the ability
of CTCF to recruit CtIP at DNA lesions (Figure 5) con-
tributed to the formation of the HR initiation complex,
which conferredDNAend resection activity (Figure 6A and
B).
The earlier findings showed that CTCF is required for the
recruitment of BRCA2 (10), which targets RAD51 onRPA-
coated ssDNA, and the C-terminal domain of CTCF in-
teracts with RAD51 (11). Therefore, these CTCF–BRCA2
and CTCF–RAD51 interactions likely contribute to the
RAD51 presynaptic/synaptic complex assembly. In addi-
tion, we herein found that CTCF acts at DSB resection, a
step upstream of RAD51 filament assembly in cooperation
with BRCA2 (10,11). Taken together, our results, as well
as previously published results, reveal the multifaceted role
of CTCF in HR-mediated DSB repair. In addition, CTCF-
depleted cells succumbed to etoposide, which was signifi-
cantly more hypersensitive than that of CtIP-depleted cells
(Figure 7C). Furthermore, the etoposide sensitivity of dou-
ble CTCF- and CtIP-depleted cells was not dissimilar from
that of CTCF-depleted cells in asynchronized status, but
was subtly increased in S/G2 phases (Figure 7C), indicating
that, although CTCF and CtIP likely function in the same
pathways during DNA repair, CTCF may have additional
roles in DNA damage responses. As a transcription factor
or chromatin organizer, CTCFwould furthermanageDNA
damage in addition to HR.
Our results also showed a novel attribute and role of
CTCF in the first control point of DSB repair at the DNA
end resection step of HR-mediated repair (Figure 7B and E;
Supplementary Figure S10A). Thus, the findings from our
study extend the understanding of how CTCF contributes
to DNA damage repair and tumor suppression functions.
Elucidating the mechanisms for HR has important implica-
tions in understanding tumor pathogenesis and therapy. Tu-
mors depleted in BRCA1 and BRCA2 are severely impaired
in HR, and are therefore sensitive to therapies that utilize
PARP inhibitors. Based on our study, depletion of CTCF
renders wild-type BRCA1/2 cancer cells HR-incompetent.
These results could be used to develop new therapeutic
strategies for HR-competent tumor therapy with PARP in-
hibitors.
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